M. Lebwohl, “A Phase 3b Study Evaluating Safety and Efficacy of Risankizumab in Adult Patients with Moderate-to-Severe Plaque Psoriasis with Palmoplantar (Non-Pustular) Involvement”, J of Skin, vol. 7, no. 6, p. s256, Nov. 2023.